GNI GNI GROUP LTD.

Contact Us
About Us
  • About Us TOP
  • Message
  • Business Model
  • Main Products
  • Management Policy
  • Company Overview
  • Board of Directors
  • Main Group Structure
  • Office
  • Corporate governance
R&D
  • R&D TOP
  • Pipeline
  • Discovery Research
  • Research publications
Investor Relations
  • Investor Relations TOP
  • IR News
  • Information
  • IR Materials
  • IR Calendar
  • IR Email Subscription
  • Electronic Public Notices
Sustainability/ESG
  • Sustainability/ESG TOP
  • Sustainability Initiatives
  • ESG Data
Contact Us
Site Map
Privacy Policy
Terms of Use
ソーシャルメディアポリシー

2008's Information

トップページInformation2008年
2008/12/19
Notice of Granting Stock Option to Consultants
2008/12/05
Notice of Exercise Price of Stock Option etc
2008/11/20
Notice of Increasing the Capital of ShanghaiGenomics
2008/11/20
Notice of Granting Stock Option to Consultants
2008/11/13
Changing the Granting Date of Stock Option
2008/10/21
Notice of Cancellation of the Share Purchase Agreement with Evo Fund
2008/10/17
Notice of Cancellation of the 4th Stock Issuance in Private Placement Offerings
2008/09/25
GNI Announces Strategy for Seeking Early Conditional Approval of F647 for the treatment of Idiopathic Pulmonary Fibrosis in China
2008/09/10
Notice of Cancellation of the 3rd Stock Issuance in Private Placement Offerings
2008/09/01
Notice of the Resignation of the Auditor and the Inauguration of the Officer
  • 1
  • 2
  • 3
  • 4
  • 5
  • >
画像

GNI

About Us
Message
Business Model
Main Products
Management Policy
Company Overview
Board of Directors
Main Group Structure
Office
Corporate Governance Policy
Investor Relations
IR News
IR Materials
IR Calendar
Electronic Public Notices
IR Email Subscription
R&D
Pipeline
Discovery Research
Research publications
Sustainability/ESG
Sustainability Initiatives
ESG Data
Contact Us
Career
Site Map
Privacy Policy
Terms of Use
Social Media Policy
Site Map
Privacy Policy
Terms of Use
Social Media Policy

© GNI Group Ltd. All Rights Reserved.